v3.26.1
Organization - Schedule of Principal Subsidiaries (Details)
12 Months Ended
Dec. 31, 2025
VVAX Skyline Holdings Limited (“VVAX Skyline”) [Member]  
Schedule of Principal Subsidiaries [Line Items]  
Date of incorporation/ acquisition Apr. 03, 2023
Place of incorporation British Virgin Islands
Percentage of direct or indirect ownership by the Company 100.00%
Principal activities Investment holding
Windsor Holdings Co., Ltd. (“Windsor Holdings”) [Member]  
Schedule of Principal Subsidiaries [Line Items]  
Date of incorporation/ acquisition May 30, 2023
Place of incorporation British Virgin Islands
Percentage of direct or indirect ownership by the Company 100.00%
Principal activities Investment holding
Peg Biotechnology (HK) Holding Limited (“Peg Biotechnology”) [Member]  
Schedule of Principal Subsidiaries [Line Items]  
Date of incorporation/ acquisition Apr. 18, 2023
Place of incorporation Hong Kong
Percentage of direct or indirect ownership by the Company 100.00%
Principal activities Investment holding
Hainan Senhan Biotechnology Co., Ltd. (“Hainan Senhan”) [Member]  
Schedule of Principal Subsidiaries [Line Items]  
Date of incorporation/ acquisition May 22, 2023
Place of incorporation PRC
Percentage of direct or indirect ownership by the Company 100.00%
Principal activities Investment holding
Jilin Zhengye Biological Products Co., Ltd. (“Jilin Zhengye”) [Member]  
Schedule of Principal Subsidiaries [Line Items]  
Date of incorporation/ acquisition May 18, 2004
Place of incorporation PRC
Principal activities Research, development, manufacture and sales of veterinary vaccines
Jilin Zhengye Biological Products Co., Ltd. (“Jilin Zhengye”) [Member] | Hainan Senhan [Member]  
Schedule of Principal Subsidiaries [Line Items]  
Percentage of direct or indirect ownership by the Company 58.689%
Jilin Zhengye Biological Products Co., Ltd. (“Jilin Zhengye”) [Member] | Windsor Holdings [Member]  
Schedule of Principal Subsidiaries [Line Items]  
Percentage of direct or indirect ownership by the Company 25.1524%
Beijing Zhongnong Zhengye Biotechnology Co., Ltd. (“Beijing Zhengye”) [Member]  
Schedule of Principal Subsidiaries [Line Items]  
Date of incorporation/ acquisition Apr. 16, 2025
Place of incorporation PRC
Percentage of direct or indirect ownership by the Company 51.00%
Principal activities Sales of veterinary vaccines